Non-alcoholic Steatohepatitis Registry Platform Study | MicrobiomeTrials← Back to trialsNCT06123858
Non-alcoholic Steatohepatitis Registry Platform Study
TERMINATEDOBSERVATIONAL
Trial Details
Start: 2023-11-22Est. Completion: 2025-10-17
Enrollment target: 1,122 participants Locations- Research Site, Beijing, China
- Research Site, Changchun, China
- Research Site, Chengdu, China
- Research Site, Fuzhou, China
- Research Site, Guangzhou, China
- Research Site, Hangzhou, China
- Research Site, Inner Mongolia, China
- Research Site, Nanchang, China
- Research Site, Qingdao, China
- Research Site, Shanghai, China
- Research Site, Shenyang, China
- Research Site, Taiyuan, China
- Research Site, Tianjin, China
- Research Site, Wenzhou, China
- Research Site, Xi'an, China
- Research Site, Zhengzhou, China
Other microbiome trials you might be interested in
ResilienceCognitive Function and Well-BeingMuscle Function, Handgrip Strength TestInsulin Sensitivity
Sarcopenia, characterized by the progressive loss of muscle mass and strength in older adults, is a key factor in health…
Santiago, ChileEst. completion Jun 17, 2026
Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease (NAFLD)MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLD
NAFLD
Metabolic Dysfunction-Associated Steatotic Liver Disease
NAFLD (Nonalcoholic Fatty Liver Disease)
NAFLD (Non-alcoholic Fatty Liver Disease)
NAFLD - Non-Alcoholic Fatty Liver Disease
NAFLD - Nonalcoholic Fatty Liver Disease
The goal of this clinical trial is to learn if daily supplementation with Low-methoxy (LM) pectin (polysaccharides extra…
Nottingham, United KingdomEst. completion Mar 31, 2027